Association of XRCC1 variants with acute skin reaction after radiotherapy in breast cancer patients

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 6, 2010, Pages 681-685

  Zhou, Liqing ^a   Xia, Jianhong ^b   Li, Hongliang ^b   Dai, Jianrong ^a   Hu, Yimin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b The First Hospital of Huaian   (China)

Author keywords

acute skin reaction; breast cancer; radiotherapy; single nucleotide polymorphism; XRCC1

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TOXICITY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RADIATION INJURIES; RISK FACTORS; SKIN;

EID: 78651305624     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0811     Document Type: Article

References (37)

1. Barber JB, Burrill W, Spreadborough AR, et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 2000;55:179.
2. Fernando IN, Ford HT, Powles TJ, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 1996;8:226.
3. Turesson I, Nyman J, Holmberg E, et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065.
4. Twardella D, Popanda O, Helmbold I, et al. Personal char-acteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an un-selected cohort of breast cancer patients receiving radiother-apy. Radiother Oncol2003;69:145.
5. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 1992;28A:1783.
6. Chang-Claude J, Popanda O, Tan XL, et al. Association be-tween polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005;11:4802.
7. Giotopoulos G, Symonds RP, Foweraker K, et al. The late radiotherapy normal tissue injury phenotypes of telan-giectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 2007;96: 1001.
8. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366.
9. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453.
10. Whitehouse CJ, Taylor RM, Thistlethwaite A, et al. XRCC1 stimulates human polynucleotide kinase activity at dam-aged DNA termini and accelerates DNA single-strand break repair. Cell 2001;104:107.
11. Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair (Amst) 2003;2:955.
12. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res 2000;459:1.
13. Zhang X, Miao X, Liang G, et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005;65:722.
14. Mohrenweiser HW, Xi T, Vazquez-Matias J, et al. Identifi-cation of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Bio-markers Prev 2002;11:1054.
15. Hao B, Miao X, Li Y, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished pro-moter activity and increased risk of non-small cell lung cancer. Oncogene 2006;25:3613.
16. Patel AV, Calle EE, Pavluck AL, et al. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymor-phisms and breast cancer risk. Breast Cancer Res 2005;7: R1168.
17. Miao X, Zhang X, Zhang L, et al. Adenosine diphosphate ribosyl transferase and X-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology 2006;131:420.
18. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956.
19. Muss HB, Cooper MR, Brockschmidt JK, et al. Arandomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer: Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 1991;19:77.
20. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiationtherapy after chemotherapy in breast cancer patients treated with mas-tectomy. J Clin Oncol 1987;5:1546.
21. Olson JE, Neuberg D, Pandya KJ, et al. The role of radio-therapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 1997;79:1138.
22. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cance Coopera-tive Group 82b Trial. N Engl J Med 1997;37:949
23. The Common Terminology Criteria for Adverse Events (CTCAE) v3.0. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf. Accessed July 1, 2004.
24. Hu Z, Ma H, Lu D, et al. A promoter polymorphism (77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Phar-macogenet Genomics 2005;15:457.
25. Andreassen CN, Alsner J, Overgaard M, et al. Prediction of normal tissue radiosensitivity from polymorphisms in can-didate genes. Radiother Oncol 2003;69:127.
26. Andreassen CN, Alsner J, Overgaard J, et al. TGFB1 poly-morphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 2005;75:18.
27. Andreassen CN, Alsner J, Overgaard M, et al. Risk of radiation-induced subcutaneous fibrosis in relation to sin-gle nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from for-malin fixed paraffin embedded tissue samples. Int J Radiat Biol 2006;82:577.
28. Brem R, Cox DG, Chapot B, et al. The XRCC1-77T->C variant: Haplotypes, breast cancer risk, response to radio-therapy and the cellular response to DNA damage. Carci-nogenesis 2006;27:2469.
29. Burri RJ, Stock RG, Cesaretti JA, et al. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res 2008;170:49.
30. Chang-Claude J, Ambrosone CB, Lilla C, et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 2009;100:1680.
31. De Ruyck K, Van Eijkeren M, Claes K, et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 2005;62:1140.
32. Moullan N, Cox DG, Angele S, et al Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003;12:1168.
33. Popanda O, Marquardt JU, Chang-Claude J, et al. Genetic variation in normal tissue toxicity induced by ionizing ra-diation. Mutat Res 2009;667:58.
34. Suga T, Ishikawa A, Kohda M, et al. Haplotype-based analysis of genes associated with risk of adverse skin reac-tions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007;69:685.
35. Suga T, Iwakawa M, Tsuji H, et al. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:808.
36. Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: A systematic review. Radiother Oncol 2009;92:299.
37. Alsner J, Andreassen CN, Overgaard J. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 2008;18:126.